A world leader in biotechnology development and manufacturing has officially launched its new Billingham BioCampus, following £3.6million of support from the Tees Valley Mayor and Combined Authority. FUJILFILM Diosynth Biotechnologies supports partners in the biopharmaceutical industry with the development and…

Credit: Tees Business Global biologics company Fujifilm Diosynth Biotechnologies has announced a multi-million-pound investment to “significantly increase” its manufacturing capabilities. The Texas-based firm already employs 850 people at its Billingham site, where it’s producing 60 million doses of the Novavax…

Pre-tax profits have increased slightly at the Billingham-headquartered UK arm of a cell culture, microbial fermentation and gene therapy specialist, newly filed accounts have revealed. FUJIFILM Diosynth Biotechnologies supports customers with the development and production of recombinant proteins, viral vaccines…

The UK has secured 60 million doses of the Novavax vaccine which will be made in Billingham. The development of a covid-19 vaccine to be made on Teesside has taken a huge step forward after tests showed it is largely…

FUJIFILM Corporation is making an investment of more than 200 Billion yen (2 Billion USD) to establish a new large-scale cell culture production site in the United States to accelerate the growth of its biopharmaceutical contract development and manufacturing business…

FUJIFILM Diosynth Biotechnologies, is pleased to share that Steve Bagshaw, non-executive chairman of FUJIFILM Diosynth Biotechnologies, has been awarded Commander of the Most Excellent Order of the British Empire (CBE) for Services to the U.K. Manufacturing and Biotechnology Sector in…